Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2017-12-01
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01XC03
|
| gptkbp:biosimilar |
gptkb:Herceptin
|
| gptkbp:brand |
trastuzumab-dkst
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
solution for infusion
|
| gptkbp:genericName |
trastuzumab-dkst
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ogivri
|
| gptkbp:indication |
gptkb:cancer
gastric cancer |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Biocon
gptkb:Mylan |
| gptkbp:mechanismOfAction |
gptkb:monoclonal_antibody
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:target |
gptkb:HER2_receptor
|
| gptkbp:bfsParent |
gptkb:trastuzumab
gptkb:Biocon_Biologics |
| gptkbp:bfsLayer |
7
|